Live feed
Filing
SC 13D
SC 13D0001144204-16-090886·Immunoclin Corp
Schedule 13D ownership disclosure
Immunoclin Corp
Security class unavailable · CUSIP: 45256L109
Event date: 2013-12-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,000,000
- Percent of class
- 16.0400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-090886
- Form type
- SC 13D
- Filer
- Immunoclin Corp
- CIK
- CIK 1520047
- Filed
- Mar 29, 2016
- Reporting period
- Dec 13, 2013
- Description
- Schedule 13D beneficial ownership